Insurance by BogdanovaThe Encyclopedia of Insurance and Risk Science

RESEARCH DOSSIER

Rate Filings and Actuarial Justification in Insurance

Abstract. Insurance rate filings communicate proposed premium schedules, changes to rating rules, and the evidence supporting their use under an applicable regulatory system. Their institutional forms vary considerably. The scientific problem is the defensible estimation of future insured costs from incomplete historical evidence while accounting for policy design, exposure composition, loss development, inflation, catastrophe risk, expenses, reinsurance, capital, model uncertainty, and the rights and behavior of insured consumers. This monograph studies rate filings as a joint actuarial, evidentiary, and institutional practice. It distinguishes technical rate indications, filed tariffs, charged prices, and administrative decisions; reconstructs pure-premium and loss-ratio reasoning; analyzes frequency–severity and multivariate methods; and provides transparent numerical examples of credibility, class relativities, profit provisions, and selected changes below the indicated level. It compares United States state-based review with European tariff-pricing provisions, British conduct rules, Ontario automobile-filing guidance, and United States health-market procedures. The original contribution is an integrated interpretation of the relations among prospective-cost estimation, legal filing regimes, rate-classification evidence, and consumer outcomes, supported by author-constructed calculations. The governing conclusion is that defensible rate justification requires coherent correspondence among the projected cost object, underlying observations, permitted variables, model uncertainty, decision exhibits, implemented tariff, and claim submitted for regulatory determination. The work develops an analytical synthesis without asserting a new pricing doctrine or empirical model.

Keywords: Insurance ratemaking; rate filings; actuarial justification; prospective loss cost; rate adequacy; prior approval; file-and-use; use-and-file; SERFF; on-level premium; loss development; credibility; generalized linear models; catastrophe provisions; cost of capital; risk classification; consumer pricing; supervisory review; data provenance.

Introduction

An insurer normally prices a policy before its claims have been reported, developed, litigated, adjusted, and settled. Historical payments and incurred losses provide evidence about future obligations, but the object being priced is the prospective cost of the contractual promise. The connection between the selected rate and expected future cost is expressed by the Casualty Actuarial Society's ratemaking statement of principles and investigated systematically by Werner and Modlin (2016) in Basic Ratemaking, fifth edition. The Casualty Actuarial Society has published errata for that edition, an additional reason to cross-check reproduced examples and formulas rather than treat any textbook as infallible.

The term rate filing denotes a procedural object only in a specified jurisdiction. In one United States state an insurer may require prior approval, in another a filing may precede use without an affirmative approval, and in another use may precede filing. European supervision is organized differently for systematic prior approval of non-life tariff scales. Every procedure can involve evidence about insurer costs and consumer prices, but the legal mandate and the event that constitutes permission to use a rate vary. The NAIC's survey of rate-filing methods establishes the essential procedural vocabulary.

Four objects must remain distinguishable throughout analysis. A technical indication estimates future premium requirements for a specified policy and portfolio under explicit assumptions. A filed rate proposal states the schedule, rating rules, classifications, and requested changes actually submitted. The implemented premium is the price resulting from the approved or otherwise permissible manual, discounts, surcharges, and business practices. A regulatory decision determines compliance under an applicable process and legal standard. Their relationships are material: an internally sound indication can support a proposed increase different from its calculated value, and regulatory authorization is not a certification that the underlying estimate will be realized.

Methodologically, this work compares official regulatory texts and professional actuarial standards with established ratemaking scholarship. It reconstructs equations, evaluates their assumptions, and uses explicitly hypothetical aggregate numerical examples to make mathematical and decision consequences inspectable. The examples contain no observed insurer experience and no inference about a particular insurer's warranted premium. Technical standards are discussed only within their actual scope and effective dates, and cross-border analogies preserve legal differences.

Rate Filing Objectives and Jurisdictions

Filing purpose and decision traceability

An insurance tariff affects a payment for promised contingent performance. The conventional United States property/casualty review evaluates proposed rates against jurisdictional requirements commonly phrased in terms of excessiveness, inadequacy, and unfair discrimination. The Product Filing Review Handbook describes the documentation regulators may expect concerning experience periods, current rate level, indicated changes, class plans, exhibits, and compliance. This language does not eliminate local statutory differences. Each regulatory authority specifies the operative tests and evidence.

A rate filing is best understood as a chain of identifiable transformations: source transactions and exposure data; valuation and historical normalization; ultimate loss estimates; future trend and risk adjustments; expense and profit estimates; technical indication; management's proposed change; implemented rating manual; and regulator's treatment of the filing. Every transformation can alter a result. If losses refer to one policy form and exposures to another, the final indication lacks a stable subject. If a class exhibit calculates factors not implemented in the rating manual, the filing does not explain the actual prices the insurer intends to charge.

The filing record should identify legal insurer, line of business, product, forms, territory, covered period, prior and proposed rates, intended effective date, aggregate premium change, distribution of policyholder changes, data sources, actuarial methods, and a record of material assumptions. Particular regulator forms may prescribe additional schedules or remove elements irrelevant to a specific filing. The California Department of Insurance's November 2026 filing instructions illustrate a detailed prior-approval framework, while its published rate-review process describes examination of application completeness and actuarial support.

Comparative procedural regimes

The NAIC's 2025 chart classifies several procedures. Under prior approval, a company ordinarily seeks authorization before using a proposed schedule. Under modified prior approval, certain changes can follow a different path. Flex rating relates filing requirements to change-size thresholds. File-and-use contemplates filing before use without necessarily awaiting affirmative approval. Use-and-file allows use followed by filing within a prescribed period. No-file systems omit routine rate filing but can preserve substantive rating law and supervisory examination. The NAIC jurisdictional comparison should be used to identify a state's procedures at the applicable time, not to replace an examination of its code and instructions.

Regulatory method Filing and implementation relationship Evidence question
Prior approval Regulator ordinarily approves before use Does the submitted proposal satisfy applicable legal tests?
Modified prior approval Approval required for designated changes Which changes qualify for the alternative procedure?
Flex rating Threshold conditions determine approval requirement How is the change measured against the threshold?
File-and-use Filing ordinarily precedes implementation What can the authority challenge after filing?
Use-and-file Filing follows implementation within specified time Are records and post-use review requirements satisfied?
No-file No routine tariff submission Which substantive limits and examination rights remain?

Electronic workflow changes the handling of documents, not the legal meaning of the filing. The NAIC's electronic rates and forms platform supports electronic exchange and review and offers public filing access through participating regulatory arrangements. A verifiable history should distinguish initial submission, supplemental exhibits, regulator objections, amended pages, authorization or disapproval, and implementation date. These events may differ significantly from the date of the first actuarial calculation.

The European institutional contrast

The European Union's Solvency II Directive, Articles 181–182 sets out a substantially different framework for premium-scale control. Its provisions generally preclude member states from requiring systematic prior approval or notification of non-life insurance premium scales, subject to expressed qualifications for certain statutory circumstances. Technical-basis provisions in life insurance have distinct qualifications. This framework should be read alongside national contract, competition, conduct, and prudential law. It would be erroneous to infer that European authorities therefore lack supervisory concern about risk pricing or consumer treatment. Their institutions may evaluate insurer governance, solvency, fair treatment, and relevant consumer-harm practices through instruments other than an ordinary tariff preapproval application.

The United Kingdom illustrates a conduct-focused intervention. FCA rules for specified home and motor products restrict the renewal premium in relation to the equivalent new-business price. The regulator's pricing-practices questions and answers distinguish risk price and commercial pricing components and explain the operational rule. The FCA's evaluation of the pricing remedies addresses tenure-based price walking, outcomes for customers, and possible market effects. These rules concern particular renewal and distribution practices, rather than a universal legal requirement to submit each actuarial indication to a public prior-approval board.

Ontario illustrates the importance of primary-source caution. The FSRA's automobile filing guidance page discusses filing design, actuarial support, price differentiation, and review. Its public presentation labels the guidance as “Proposed” while describing a March 1, 2026 effective date in its text. For this comparative monograph the document demonstrates supervisory priorities; its currently legally operative status should be established from authoritative Ontario material before relying on a particular administrative filing route. An apparent effective date on a proposed-material page cannot alone establish that a filing requirement took legal effect.

Health insurance uses a specialized process. The U.S. Centers for Medicare & Medicaid Services provides Unified Rate Review application materials for regulated individual and small-group products. The form and rating structures reflect health-specific federal and state requirements, risk pools, and prescribed disclosure. A property/casualty loss-ratio exhibit is therefore not interchangeable with a federal health-rate template. Actuarial professional standards also distinguish product domains; ASB's life and annuity pricing standard addresses future sales of those products, and cannot be collapsed into one universal property/casualty filing rule.

Administrative validity and actuarial evidence

An approval confirms a decision under the applicable procedure and assembled record. It cannot remove future claim randomness, establish a vendor model's empirical truth, or predetermine the insurer's realized underwriting return. Rejection or delay can arise from a filing's legal, documentary, classification, or procedural shortcomings, independent of the plausibility of its aggregate expected-loss estimate. This distinction matters when readers compare regulatory decisions across markets with different statutes and supervisory responsibilities.

Rate Adequacy Support

Prospective insurance cost

The primary actuarial task is to estimate costs associated with future risk transfer for policies expected to be effective over a defined period. The relevant U.S. professional guidance includes ASOP No. 53, Estimating Future Costs, governing applicable prospective property/casualty work. It emphasizes the purpose of the actuarial services, the selection of appropriate methods, prospective component costs, material assumptions, and communication. Its applicability is neither universal for all global insurance products nor a substitute for a statutory rate formula.

Let expected exposures be E; prospective losses and loss adjustment expenses be L; fixed and non-premium-proportional expenses be F; separately estimated catastrophe provision be C; net reinsurance cost not embedded elsewhere be R; and other fixed assessments be K. Let premium-variable expense ratio be v and a selected underwriting-profit provision, as a ratio to premium, be q. In a simplified undiscounted single-period framework,

P∗=L+F+C+R+K1−v−q,1−v−q>0.P^*=\frac{L+F+C+R+K}{1-v-q},\qquad 1-v-q>0.

The indicated per-exposure premium is r∗=P∗/Er^*=P^*/E, and the indicated change compared with current on-level average r0r_0 is g=r∗/r0−1g=r^*/r_0-1. These are transformations of the insurance pricing identity discussed in Werner and Modlin's ratemaking text. They require careful component definition: if L already contains catastrophe loss or R already includes reinsurance cost through a net-loss basis, the separately added amount must be removed. The profit proportion q is an illustrative specification rather than an empirically justified universal capital charge.

Historical normalization

Claims and exposure records must be aligned by accounting and actuarial timing. Accident year, calendar year, policy year, underwriting year, and report year answer different questions. A claim made several years after an insured event may be attributed differently according to which convention is chosen. The actuary should define the loss development triangle, report maturity, payment status, ultimate development method, allocation of claim adjustment expenses, treatment of large claims, salvage and subrogation, and gross versus net basis.

Earned premium is generated under rates and rules that often changed during the observation window. The analyst must restate it to a suitable common rate level before using it as a denominator for a prospective loss-ratio indication. The selected on-level factor depends on written and earned premium patterns, policy-term distribution and the dates of changes. Multiplying all historical earned premium by the most recent nominal rate change without accounting for earning proportions can systematically distort the comparison.

Cost trend bridges experience and the future loss period. If historical ultimate cost per exposure at a midpoint is $100, future compound cost growth is 5% annually, and the trend interval is 1.5 years, the trend factor is 1.051.5≈1.075931.05^{1.5}\approx1.07593; projected loss cost is about $107.59 before other adjustments. A straight 7.5% convention would produce a slightly different figure and should be identified if used. The choice of loss-period midpoint, policy duration, and reporting basis is as consequential as a seemingly small difference in the annual trend percentage.

Frequency and severity deserve separate assessment when they evolve differently. A 3% frequency increase with 4% severity growth implies combined cost growth of 1.03×1.04−1=7.12%1.03\times1.04-1=7.12\%, rather than simply 7%. Components may be affected by repair labor, medical inflation, liability litigation, road safety, weather, hazard mitigation, policy deductibles, or behavioral changes. A filing should explain whether claimed cost trends arise from data, external benchmarks, model projections, or explicit professional judgment and whether they overlap other adjustments.

Catastrophes and reinsurance

Large catastrophe events require modeling beyond naive short-history averaging. ASOP 39 on catastrophe losses concerns appropriate treatment of sparse, extreme events, including modeling and use of external information for property/casualty ratemaking. A short experience period with no hurricane does not prove zero hurricane cost; a period containing one extreme event does not necessarily justify projecting the full observed exceptional loss every year. A credible catastrophe provision assesses hazard, vulnerability, exposure concentration, policy terms, stochastic event frequencies and severity, and uncertainty in vendor inputs.

The distinction between modeled catastrophe cost and claims already included in ultimate losses must be documented. If historical catastrophe losses are removed before inserting a separately modeled allowance, the removal method and its effect need reconciliation. If ordinary claims estimates already include some extreme-event allowance, adding the vendor model's entire figure risks double counting. Related issues arise for demand surge, reconstruction inflation, reinsurance retention, catastrophe bonds, and regional aggregation.

A reinsurance expense may involve ceded premium, expected recoveries, reinstatement premiums, commissions, occurrence and aggregate limits, attachment points, and counterparty credit risk. Gross and net loss definitions should be consistent with reinsurance treatment. Insurer cost of risk is not necessarily captured by the reinsurer's premium alone, because the ceding insurer retains loss layers and may benefit from reduced risk capital. A documented filing should identify the selected convention and show how contractual risk transfer enters the cost calculation.

Expenses, profit, and timing

Administrative, claims handling, acquisition, distribution, insurance taxes, compulsory levies, and investment or financing effects can enter a premium indication differently. Certain expenses scale with premium; others scale with policies, insured assets, transactions or claims. Under the illustrative income/outgo model, expenses proportional to premium appear in the denominator. The same rate cannot properly use a numerator that includes proportional commissions and also subtract their proportion in the denominator.

Capital and profit provisions should be examined with consistent financial assumptions. ASOP No. 30, Profit and Contingency Provisions, discusses how underwriting profit, contingencies and the cost of capital enter property/casualty ratemaking. A selected percentage of premium is an assumption whose economic rationale must be recorded. Underwriting profit and total shareholder return differ because investment earnings, reserves, taxation, capital financing, risk absorption, and payment timing influence outcomes.

Cash-flow timing and discounting can matter materially for long-tail coverage. The currently applicable ASOP No. 20, Analysis of Property/Casualty Cash Flows, was revised in December 2025 and became effective June 1, 2026. Relevant considerations include discount rates, projected nominal cash flows, risk assumptions and appropriate disclosure. Discounting claim amounts while inconsistently mixing real and nominal inflation, or omitting associated cash flows, undermines interpretation. Local law may prescribe certain premium or investment treatments even when an unconstrained financial model would differ.

Pure-premium and loss-ratio calculations

The pure-premium approach estimates loss and associated fixed cost per exposure, then accounts for expenses and profit. The loss-ratio approach compares projected losses and loss-related expenses against premiums restated to the appropriate current level. Under aligned exposure definitions, prospective assumptions, and expense allocation, the approaches are alternative expressions of the same underlying pricing identity. A meaningful discrepancy between them indicates a possible difference in on-level premium, business mix, development, expense definition, or selected projection; it is not an invitation to choose whichever number is commercially easier.

The indication inherits multiple forms of uncertainty. Process variation concerns future claims even if the data-generating mechanism were known. Parameter estimation concerns uncertainty about loss frequency, severity and trend. Model uncertainty concerns which specification is appropriate. Structural uncertainty concerns changes in law, economic conditions, insurance demand, climate, litigation and policy terms. A good filing evaluates the sensitivity of material results to plausible assumptions and separates deterministic alternatives from estimates of probability.

A fully specified numerical example

Consider an explicitly invented portfolio with current on-level average premium of $1,050 per exposure. The following costs are expected per exposure for a future one-year period; none represents actual market experience:

Component Illustrative future cost per exposure
Ordinary losses and loss adjustment $720
Fixed acquisition and administration $110
Separately defined catastrophe allowance $75
Net reinsurance cost not otherwise included $35
Other fixed assessments and provisions $25
Total fixed prospective cost $965

Assume premium-variable expenses of 18% and a target underwriting-profit fraction of 5%. The resulting indication is 965/(1−0.18−0.05)=965/0.77=$1,253.25965/(1-0.18-0.05)=965/0.77=\$1,253.25, rounded to cents. Against $1,050, the indicated increase is 1,253.246753/1,050−1=19.36%1,253.246753/1,050-1=19.36\%, rounded to two decimals. No jurisdictional test is being applied to the chosen profit margin.

Three conditional sensitivities show how the estimate depends on its assumptions. An additional 2% increase affecting only the $720 ordinary-loss component raises the numerator by $14.40, generating a premium of $1,271.95. A 50% increase in the $75 catastrophe provision adds $37.50 and yields $1,301.95. Increasing the target profit provision from 5% to 7%, holding the numerator and v fixed, produces 965/0.75=$1,286.67965/0.75=\$1,286.67. These figures arise from arithmetic, not estimated market probabilities. The first and second are cost scenarios; the third changes the chosen financing and return specification. Their distinct meanings should be preserved.

Data and Modeling Exhibits

Data quality and material provenance

The actuarial conclusion cannot exceed the reliability of the underlying evidence. ASOP No. 23, Data Quality, addresses the selection, review, use and reliance on data in covered actuarial work. A rate-filing data dictionary should identify the insured object, policy and coverage periods, claim occurrence and reporting dates, earned exposures, premium transaction dates, policy limits, deductibles, territories, event codes, loss and adjustment expense fields, gross/ceded distinctions, source systems and extract versions.

The analyst should reconcile record counts and loss and premium totals against stable controls. Exclusions, imputation, policy cancellations, retrospective adjustments, duplicate claims, re-opened claims and negative recovery balances should be identified and assessed. A model may generate highly consistent predictions against a flawed target variable; this numerical consistency cannot substitute for field-level source validity. The data source should be traceable through each cleaning and development step to the final exhibits.

Data maturity creates a distinctive hazard. Recent underwriting cohorts may look unusually profitable when losses are reported late or when settlement severity subsequently rises. A random train/test split that uses future-adjusted claim outcomes may leak information that would have been unavailable at the assumed filing date. For prospective validation, the analyst should reconstruct the information available at the actual decision cutoff and explain how late development is handled.

A coherent exhibit sequence

A reviewable rate submission commonly benefits from a concise executive indication, portfolio overview, rate-level restatement, exposure and claims reconciliation, ultimate loss and loss-adjustment analysis, trend estimates, catastrophe and reinsurance support, fixed and variable expenses, profit provisions, rating classification and model exhibits, policyholder impact distributions, and final rate manual reconciliation. The order should make dependencies visible. Local instructions may prescribe additional schedules or more restrictive templates. The California filing package and the regulatory review handbook demonstrate how statutory forms and technical support can be connected.

Every major exhibit should state numerator, denominator, unit, experience dates, valuation date, prospective period, selected assumptions, alternatives, source and effect on the proposed change. An ultimate-loss exhibit without an exposure definition cannot be reproduced coherently. A trend exhibit without its selected interval cannot be reconciled to the final costs. A policyholder-impact table calculated on an obsolete rating manual does not document the proposed implemented result.

Frequency–severity and generalized linear models

For a simple frequency model with exposure eie_i, explanatory variables xix_i, and claim count NiN_i, a log-link Poisson specification can be written:

log⁡E⁡[Ni]=log⁡(ei)+xiTβ.\log\operatorname{E}[N_i]=\log(e_i)+x_i^{\mathsf T}\beta.

Here log⁡(ei)\log(e_i) is an offset representing comparable time or insured risk units. Conditional positive severity can be modeled with appropriate gamma, lognormal or other distributions, with attention to heavy tails, inflation and policy limits. The projected pure premium relates claim count and size while respecting their possible dependence. A compound Poisson–gamma process leads to a Tweedie response under suitable assumptions, useful for a combined distribution with zeros and positive continuous losses.

Anderson and colleagues (2007) address practical generalized linear model construction in their CAS practitioner's guide. Frees, Meyers, and Cummings (2011) analyze alternative formulations in multi-peril homeowners modeling, including validation of frequency and loss-cost behavior. These sources support the comparison of methods, but no coefficient or empirical distribution reported for one portfolio should be transported into another insurer's pricing without evidence of comparability.

Generalized linear models are interpretable relative to more complex alternatives, but interpretability still requires disclosure of links, variable coding, interactions, offsets, baseline factors, missing-value treatment, constraints, shrinkage and calibration. A model with statistically impressive in-sample results can perform poorly if the price environment changes or if small classes have unstable loss experience.

Model selection and independent diagnostics

Model selection must begin with an explicit purpose and a specified forecasting period. Goodness-of-fit, deviance and predictive rankings are relevant diagnostics but answer different questions from economic adequacy, compliance and price stability. A model should be tested against a simpler benchmark, alternative segmentation and plausible stress scenarios. Validation must consider claim maturity, time-separated holdouts, territorial transfer, event concentration and variation across product forms. A review should show where the model is wrong as well as where it fits.

Frees, Meyers, and Cummings (2014), in Insurance Ratemaking and a Gini Index, discuss an economic measure of predictive ordering for insurance ratemaking. This measure is a useful adjunct to calibration, but it does not establish that each rate factor is lawful or distributionally fair. A model can rank risks well while systematically underpredicting overall claims cost. A high discrimination score can also be driven by variables that lack a defensible legal place in a filed classification plan.

Vendor models, AI, and controls

ASOP No. 56, Modeling, addresses the appropriateness, use, validation and communication of actuarial models within its scope. A model record should identify version, training period, input definitions, dependencies, exclusions, tested alternatives, known limitations and source-code or methodological access appropriate to the review. Where a proprietary vendor model is used, an insurer should document the validation it actually performed and distinguish vendor representations from independent evidence. Proprietary labeling is a reason to manage confidentiality, not proof of accuracy.

NAIC's artificial intelligence regulatory overview describes the 2023 model bulletin and subsequent insurance regulatory governance work. AI-based pricing proposals heighten the importance of provenance and accountability for permissible predictors and automated decisions. Irrespective of computational complexity, a rate filing should trace predicted relative costs into filed factors and actual consumer charges. If the model changes during review, the supporting exhibits should identify the change in version and resulting premium impacts.

Data security, confidentiality and auditability

The fact that actuarial calculations may use sensitive policy or claims data does not imply public access to each underlying record. A filing system can separate public exhibits from authorized supervisory data and preserve the ability of auditors to rerun key calculations. Data retention and disclosure obligations are legal matters that differ by state and country. Scientific reproducibility is a property of well-defined inputs, versions, equations and checks; public dissemination of individual claims is a separate decision subject to privacy and confidentiality law.

This dossier's hypothetical calculations are independently constructed from stated parameters and are fully reproducible. They are distinct from the primary-source statements about legal regimes, professional practice and empirical published studies. No original insurance microdata, commercial catastrophe engine or insurer filing database is claimed.

Classification and Credibility

Level versus allocation

An overall indicated rate level estimates aggregate premium needed to cover the defined expected costs. A classification plan distributes that required premium among insured segments based on their relative expected costs and legally permitted variables. These two calculations interact through exposure weights. ASOP 12 on risk classification addresses the purpose, design and professional considerations of class systems and reinforces the need to identify the actuary's applicable practice.

Suppose a portfolio has 8,000 exposures in class A at current average premium $900 and 2,000 exposures in class B at $1,600. Current premium is 8,000(900)+2,000(1600)=$10.48,000(900)+2,000(1600)=\$10.4 million, averaging $1,040 per exposure. Suppose a proposed class adjustment reduces A's rate by 8% to $828 and increases B's rate by 15% to $1,840. On the same exposure mix, the new aggregate is 8,000(828)+2,000(1840)=$10.3048,000(828)+2,000(1840)=\$10.304 million. The average becomes $1,030.40, a change of approximately −0.9231%. Although neither class change was presented as an overall level adjustment, the class-mix-weighted result changes the total premium requirement.

A neutralizing factor for this fixed mix is 10.4/10.304≈1.00931710.4/10.304\approx1.009317. Applying it to the proposed class premiums would restore the original aggregate premium, before any overall indicated change or implementation constraints. This arithmetic requires no empirical insurer data. Its role is to show why a relativity change must identify its normalization basis and exposure mix.

Credibility and sparse classes

Insurers frequently face sparse claims experience, particularly for specialized risks, small territories, new coverages and catastrophic events. Credibility procedures combine experience with broader relevant information to control estimation variance. ASOP 25 on credibility procedures provides applicable guidance concerning the use and selection of credibility approaches. A simple illustrative estimate is

m=Z mcell+(1−Z)mbenchmark,0≤Z≤1.m=Z\,m_{\mathrm{cell}}+(1-Z)m_{\mathrm{benchmark}}, \qquad 0\leq Z\leq1.

Suppose a cell estimate is $1,350, a comparable broader benchmark is $1,050, and a chosen illustration weight is Z=400/(400+600)=0.4Z=400/(400+600)=0.4. The blended estimate is 0.4(1350)+0.6(1050)=$1,1700.4(1350)+0.6(1050)=\$1,170. The number 600 is an invented credibility constant and has no claim to a full-credibility threshold in any actual filing. Real credibility weights require assumptions about within-cell variance, between-cell heterogeneity, count and severity distributions, stability and relevance of the benchmark. The example demonstrates the mechanism while preserving its evidentiary limitation.

Too much pooling can suppress authentic cost variation, whereas hyper-granular rating cells may convert random recent loss realizations into erratic premiums. Hierarchical smoothing and constrained model specification can address aspects of this tension, but their use requires calibrated assumptions and examination of downstream price differences. The actuarial justification must explain why distinctions are relevant, what data support them and whether their use is permitted.

Territorial and coverage factors

Geographic classification reflects variation in natural perils, repair costs, legal environment and insured value, but administrative boundaries are imperfect measures of risk. A sharp rating change at a postal boundary may have little physical justification without explanatory evidence. Data can be too sparse at fine spatial resolutions. An insurer should assess spatial smoothing, credible peril information, coverage and exposure concentration, while also examining whether territorial variables act as proxies for legally protected attributes.

Policy limits, deductibles, exclusions, waiting periods and other contract terms alter the probability and scale of insurer payment. An increased deductible can eliminate many small claims without proportionately reducing very large claims. Limit factors depend on the severity distribution and often on coverage provisions. Claims-made and occurrence policies involve different reporting and development dynamics. The insured contract, not a generic claim population, determines the priced object.

For catastrophe exposure, location-specific expected loss may depend on regional hazard models and aggregate concentrations, making direct cell experience especially limited. Catastrophe-loss guidance supports use of relevant information beyond a short internal claims record, while multi-peril modeling research illustrates why peril-specific models and their combination deserve separate validation. A filing should make the weighting of direct experience and model evidence explicit.

Competing class-plan models

Imagine two models aimed at the same aggregate premium: one uses a small set of established frequency and severity predictors; another uses many nonlinear interactions and third-party information. The second may outperform the first on an in-sample statistic yet be less stable across years, harder to justify legally, or poorly calibrated for uncommon risks. A proper comparison evaluates out-of-period predictive loss, class-level calibration, price sensitivity, stability, feature provenance, legal admissibility and transparency of the final manual. The decision should state which candidate was chosen and why, preserving material rejected alternatives.

The distinction between model accuracy and lawful classification is essential. A model's correlation with losses supplies an actuarial reason to examine a variable. Its admissibility depends on statutory and supervisory standards. A legally permitted feature also needs a defensible actuarial purpose. No one diagnostic can certify both.

Rate-change distribution

An aggregate filing impact can conceal major differences across policyholders. A class-level exhibit should show mean and median increases, percentiles, counts of policies receiving larger changes, maximum changes where meaningful, changes by territory and coverage, and comparison on current versus projected business mixes. A plan may be neutral for today's portfolio yet produce a different average premium after policyholder selection changes the mix. A proposal that adds discounts, new tier assignments, minimum premiums or multi-policy rules must model their actual implementation.

The resulting interpretation is that a rate filing justifies a tariff, not an isolated regression. The reviewer should be able to compute realized premiums for representative policies and reconcile their aggregate to the selected rate indication.

Consumer and Competition Effects

Adequacy, excessiveness and discrimination

Rate adequacy and fairness refer to different objects. Adequacy considers whether the premium can fund expected obligations and related provisions under a given law. Excessiveness asks whether the price violates the upper limit imposed by applicable regulation. Unfair discrimination addresses differences in treatment that violate the relevant classification and consumer-law standard. The regulatory review handbook describes these tests as they occur in U.S. product-file review; their precise legal meaning must be determined jurisdiction by jurisdiction.

Risk heterogeneity supplies an economic reason for some price differences, but it does not make every predictive correlate an acceptable rating factor. Insurance law may exclude certain classifications regardless of their statistical association with losses. Other attributes may be lawful but unreliable, sensitive to manipulation, or poorly understood by consumers. The actuarial and conduct analyses should therefore document predictive value and legal use separately.

Renewal pricing, tenure and behavioral margins

An insurer's charged price can reflect expected losses, acquisition costs, distribution expenses, competitive strategy, and policyholder switching behavior. A consumer who is unlikely to shop may be offered a higher renewal margin even if the expected claim cost is unchanged. EIOPA's statement on differential pricing practices examines unfair outcomes from such mechanisms, including price walking. The FCA's general insurance pricing rules impose specified renewal constraints for covered home and motor products. The FCA's subsequent remedies evaluation investigates changes in customer experiences and the market.

An observed price difference can result from risk, cost, margin, distribution channel or switching behavior, separately or together. Equating every price difference with insured risk would misstate the actuarial object; interpreting every difference as unlawful would also overlook permissible cost heterogeneity. A scientific assessment seeks to identify the mechanism and the legal standard relevant to the observed outcome.

Competition and dynamic availability

A prior-approval regime can produce more formal pre-use review and public participation, and it can create time between changing risk costs and permitted rate adjustments. Filing-after-use systems can permit quicker response while relying more on later examination and market conduct oversight. These are distinct regulatory designs documented by the rate-filing methods comparison, not established universal rankings of regulatory efficiency. The actual effects depend on inflation, insurer financial strength, competition, regulatory capacity, catastrophe exposure, coverage mandates, and how consumers search and switch.

Persistent underpricing can threaten availability and insurer solvency; abrupt increases can reduce access and strain households. These effects are contingent and their causal magnitudes require empirical data and a credible research design. A documentary monograph cannot attribute insurer exits or availability shortages to a particular filing rule without controlling for catastrophe experience, asset values, reinsurer terms, litigation and other simultaneous factors. This limitation should be explicit rather than silently filled with anecdote.

Distributional effects and conduct review

A 15% aggregate increase can coexist with a 50% increase for a small group, decreases elsewhere, and different impacts on existing and newly insured customers. An aggregate average does not determine whether a group is adequately credible, a rating boundary is sensible, a prohibited proxy is involved or a statutory rate cap applies. Disaggregated impact reports, sensitivity checks and rule-by-rule manual reconstruction are necessary to assess those questions.

The IAIS Insurance Core Principles framework situates conduct of business within international insurance supervision. The IAIS fair-treatment application paper addresses a wide range of consumers and recognizes risk-based pricing within considerations of fair treatment. This supports a comparative interpretation: the same consumer-protection objective may be implemented through prior-rate supervision, conduct rules, product governance, market monitoring or a combination.

Limits of fairness metrics

Predictive lift, Gini, deviance and calibration measure different aspects of forecast quality; they do not themselves resolve affordability, access, proxy discrimination or customer vulnerability. The Gini ratemaking study relates predictive ordering to insurance economics, while the differential-pricing statement concerns market behavior and consumer outcomes. The metrics answer related but distinct scientific and regulatory questions. A rate-filing record should state which criterion is being evaluated and should refrain from presenting statistical accuracy as conclusive proof of fair treatment.

Decision Records and Disclosure

The complete decision file

A regulator or independent reviewer should be able to move from final requested change to source evidence. A suitable scientific record identifies contract and line, insurer entities, effective date, experience and valuation dates, exposures, coverage changes, development, trend, catastrophe and reinsurance assumptions, expense and capital treatment, model specification and version, alternative estimates, aggregate indication, class relativities, implementation exhibits, and material uncertainty. Statutory signature, filing forms, and confidentiality requirements are set by the particular authority.

ASOP 41 on communications addresses scope, assumptions, methods, findings, reliance and limitations in covered actuarial communications. It is not a substitute for filing forms prescribed by an insurance regulator. A selection memorandum should state why the chosen trend is appropriate among plausible alternatives, how catastrophe cost was incorporated once, why credibility was selected, what validation supports the class plan, and how the final submitted factors were determined.

An informed challenge checklist

A skeptical reviewer should be able to ask: Do the current premium amounts match the existing manual? Are premiums restated to an equivalent rate level? Are claims developed to ultimate? Are future losses trended to the appropriate prospective coverage period? Are catastrophe loads and recoveries double counted? Are gross and net values mixed? Has the target profit provision already been embedded in another expense or capital assumption? Do rating variables meet the applicable law? Does the portfolio mix used for aggregate impact match the illustrated class impacts? Have modeling alternatives and material uncertainty been disclosed?

Each answer should point to a particular exhibit, source, calculation or legal provision. Changes arising from review should be preserved with a version, explanation and quantified impact. Unexplained replacement of an exhibit can destroy the audit trail even when the new arithmetic appears accurate.

A selected proposal below the indication

Return to the hypothetical $965 fixed expected cost and $1,050 current premium. The technical indication under 18% variable expenses and a 5% profit target is $1,253.25, or a 19.36% increase. Suppose management proposes only a 12% increase, setting average premium at 1050(1.12)=$1,1761050(1.12)=\$1,176. The amount available after variable expenses and the 5% target profit is 1176(1−0.18−0.05)=$905.521176(1-0.18-0.05)=\$905.52, a shortfall of $59.48 from the assumed $965 fixed cost. For a different, simpler break-even comparison that removes the target 5% profit provision, the revenue after variable expenses is 1176(1−0.18)=$964.321176(1-0.18)=\$964.32, only $0.68 below the assumed fixed cost.

The distinction between these calculations is economically significant. The selected 12% increase can be near a zero-underwriting-profit break-even point under the model and still fall materially short of the selected target profit. It should therefore be described as a management-selected proposal below the calculated indication, with its expected consequences and supporting rationale. Calling it an actuarially indicated 12% adjustment would make the technical and management decisions indistinguishable.

A catastrophe scenario increasing the fixed numerator by $37.50 would raise the indicated premium to $1,301.95 and the rate-level change to approximately 24.00%. A 7% selected profit fraction with the original cost components would raise the indication to $1,286.67, a change of about 22.54%. These conditional comparisons illustrate sensitivity rather than confidence intervals. A filing should state which assumptions are regulatory prescriptions, which derive from claims and financial evidence, and which are selected judgments.

Comparative review in one frame

Regulatory analysis should compare legal functions rather than count filings. A U.S. rate filing may be an administrative request for approval under a state law. The European framework generally restricts systematic non-life tariff preapproval under Solvency II's premium provisions. The British regime constrains specified customer-pricing practices through renewal-pricing conduct rules. Federal health insurance uses unified rate-review materials in designated markets. Ontario's automobile filing guidance articulates yet another institutional approach, subject to the stated source-status uncertainty.

Despite procedural diversity, a competent technical justification addresses the definition of insured risk, expected prospective cost, evidence quality, contractual terms, permissible classification, material uncertainty, and the connection between the mathematical indication and implemented price. This is an inference from comparative documents and actuarial methods, not an assertion that all countries have enacted the same duties.

Scope, source limitations and contribution

The primary-source review includes publicly accessible official law, regulatory publications, actuarial standards and publisher records. It is not an exhaustive search of every state insurance code, court decision, insurer filing, or current national implementation of European law. Some cited sources are publisher pages and professional abstracts rather than independent reproduction of complete underlying data. Full-network URL monitoring, proprietary catastrophe-model reconstruction, confidential insurer record examination, external peer review and market-level causal identification have not been undertaken. The public guidance-status ambiguity in Ontario is retained rather than harmonized by assumption.

The original research work consists of the international synthesis of prospective-cost analysis with institutional and consumer-pricing constraints; a clear separation of indication, filing, price and administrative disposition; and reproducible illustrative calculations for trend, expense, profit, class mix, credibility and an under-indication proposal. This contribution advances the interpretation and organization of established knowledge. No new formal pricing model, doctrine, normative principle or universally applicable rate formula is claimed.

Conclusion

A rate filing translates uncertain future contractual costs into a documented price proposal addressed to a particular legal system. Its scientific reliability depends on the specification of insured exposure, correct reconciliation of historical claims and premium, prospective development and trend, catastrophe and reinsurance treatment, expense and profit assumptions, and a model appropriate to the proposed classification. The strength of the technical conclusion depends on how transparently the final rates follow from those premises.

International comparison shows an institutional diversity of rate control. U.S. jurisdictions use different approval and filing regimes, European law generally restricts systematic prior approval of non-life premium scales, the United Kingdom addresses specified differential renewal-pricing practices, and specialized health and automobile frameworks establish additional disclosure and decision mechanisms. Their common scientific concern is the relation between measurable risk, price, evidence, consumer effects and accountable decisions, while each mechanism retains its legal specificity.

The numerical examples establish why portfolio-level funding and distribution of the premium burden must be checked separately. The same proposed class changes can alter aggregate premium through the mix of insureds. A selected requested increase can be below the technical indicated increase, with distinct implications for expected break-even and target profit. These distinctions must be disclosed in the review record. Statistical validity, legal admissibility, consumer fairness and the implementation of the rating manual require separate findings supported by relevant sources.

The substantive conclusion is that credible actuarial justification requires a coherent chain from defined policy obligations through prospective cost and classification evidence to the exact tariff and regulatory claim. A filing is scientifically inspectable when its key calculations can be reproduced, its material assumptions and alternatives are explicit, its legal requirements are accurately identified, and its consumer consequences can be examined. This is the result of the present documentary and mathematical synthesis, without an assertion of theoretical priority or external certification.

References

  • Casualty Actuarial Society. 1988; reinstated for reference in 2021. Statement of Principles Regarding Property and Casualty Insurance Ratemaking. Source record.

  • National Association of Insurance Commissioners. 2016. Product Filing Review Handbook. Kansas City, MO: NAIC. Source record.

  • National Association of Insurance Commissioners. 2025. Rate Filing Methods for Property/Casualty Insurance, Workers’ Compensation, and Title. Model Laws, Regulations, Guidelines and Other Resources, PA-10. Source record.

  • National Association of Insurance Commissioners. n.d. System for Electronic Rates & Forms Filing (SERFF): Industry Resources. Source record.

  • California Department of Insurance. 2026. Prior Approval Rate Application Filing Instructions, November edition. Source record.

  • California Department of Insurance. n.d. Rate Filing Review Process. Rate Regulation Division. Source record.

  • Werner, Geoff, and Claudine Modlin. 2016. Basic Ratemaking. 5th ed. Casualty Actuarial Society. Source record.

  • Casualty Actuarial Society Exam 5 Syllabus Committee. 2024. Errata to Basic Ratemaking, 5th Edition, by Werner and Modlin. June 27, version 1.0. Source record.

  • Actuarial Standards Board. 2017. Actuarial Standard of Practice No. 53: Estimating Future Costs for Prospective Property/Casualty Risk Transfer and Risk Retention. Effective August 1, 2018. Source record.

  • Actuarial Standards Board. 2025. Actuarial Standard of Practice No. 20: Analysis of Property/Casualty Cash Flows, Including Discounting. Effective June 1, 2026. Source record.

  • Actuarial Standards Board. 2016. Actuarial Standard of Practice No. 23: Data Quality. Revised December 2016. Source record.

  • Actuarial Standards Board. 2013. Actuarial Standard of Practice No. 25: Credibility Procedures. Effective May 1, 2014. Source record.

  • Actuarial Standards Board. 2005, updated 2011. Actuarial Standard of Practice No. 12: Risk Classification (for All Practice Areas). Source record.

  • Actuarial Standards Board. 2019. Actuarial Standard of Practice No. 56: Modeling. Effective October 1, 2020. Source record.

  • Actuarial Standards Board. 1997, updated 2011. Actuarial Standard of Practice No. 30: Treatment of Profit and Contingency Provisions and the Cost of Capital in Property/Casualty Insurance Ratemaking. Source record.

  • Actuarial Standards Board. 2000, updated 2011. Actuarial Standard of Practice No. 39: Treatment of Catastrophe Losses in Property/Casualty Insurance Ratemaking. Source record.

  • Actuarial Standards Board. 2010. Actuarial Standard of Practice No. 41: Actuarial Communications. Effective May 1, 2011. Source record.

  • Actuarial Standards Board. 2018. ASB Adopts New ASOP No. 54: Pricing of Life Insurance and Annuity Products. Adoption announcement. Source record.

  • Anderson, Duncan, Sholom Feldblum, Claudine Modlin, Doris Schirmacher, Ernesto Schirmacher, and Neeza Thandi. 2007. A Practitioner’s Guide to Generalized Linear Models. Casualty Actuarial Society. Source record.

  • Frees, Edward W., Glenn Meyers, and A. David Cummings. 2014. “Insurance Ratemaking and a Gini Index.” Journal of Risk and Insurance 81 (2): 335–366. First published online March 14, 2013. DOI: 10.1111/j.1539-6975.2012.01507.x. Source record.

  • Frees, Edward W., Glenn Meyers, and A. David Cummings. 2011. Predictive Modeling of Multi-Peril Homeowners Insurance. Casualty Actuarial Society E-Forum, Winter, Volume 2. Source record.

  • European Parliament and Council. 2009. Directive 2009/138/EC (Solvency II), especially Articles 181–182. Official Journal of the European Union. Source record.

  • European Insurance and Occupational Pensions Authority. 2023. Supervisory Statement on Differential Pricing Practices in Non-Life Insurance Lines of Business. March 16. Source record.

  • Financial Conduct Authority. 2025. Evaluation Paper 25/2: Our General Insurance Pricing Practices Remedies. July 22; updated December 3. Source record.

  • Financial Conduct Authority. 2024. General Insurance Pricing Practices: Questions and Answers on the Published Rules. Updated September 13. Source record.

  • Financial Services Regulatory Authority of Ontario. 2026. Proposed Guidance: Chapter 4 — Automobile Insurance Filing Guidance. Public guidance page. Source record.

  • Centers for Medicare & Medicaid Services. n.d. Unified Rate Review. Qualified Health Plan Certification Application Resources. Source record.

  • National Association of Insurance Commissioners. 2026. Insurance Topics: Artificial Intelligence. Model Bulletin and supervisory overview. Source record.

  • International Association of Insurance Supervisors. 2024. Insurance Core Principles: Self-Assessment Tool and Framework. December 2024 update. Source record.

  • International Association of Insurance Supervisors. 2025. Application Paper on Fair Treatment of a Wide Range of Consumers. Publication announcement, July 7. Source record.